NYSE:LTHM - Livent Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $29.03
  • Forecasted Upside: -3.35 %
  • Number of Analysts: 13
  • Breakdown:
  • 1 Sell Ratings
  • 4 Hold Ratings
  • 8 Buy Ratings
  • 0 Strong Buy Ratings
$30.03
▲ +1.69 (5.96%)

This chart shows the closing price for LTHM by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Livent Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for LTHM and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for LTHM

Analyst Price Target is $29.03
▼ -3.35% Downside Potential
This price target is based on 13 analysts offering 12 month price targets for Livent in the last 3 months. The average price target is $29.03, with a high forecast of $40.00 and a low forecast of $20.00. The average price target represents a -3.35% upside from the last price of $30.03.

This chart shows the closing price for LTHM for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 13 polled investment analysts is to buy stock in Livent. This rating has held steady since March 2022, when it changed from a Hold consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 3 buy ratings
  • 5 hold ratings
  • 1 sell ratings
2/18/2021
  • 0 strong buy ratings
  • 6 buy ratings
  • 5 hold ratings
  • 0 sell ratings
5/19/2021
  • 0 strong buy ratings
  • 6 buy ratings
  • 6 hold ratings
  • 0 sell ratings
8/17/2021
  • 0 strong buy ratings
  • 7 buy ratings
  • 6 hold ratings
  • 0 sell ratings
11/15/2021
  • 0 strong buy ratings
  • 7 buy ratings
  • 5 hold ratings
  • 1 sell ratings
2/13/2022
  • 0 strong buy ratings
  • 7 buy ratings
  • 3 hold ratings
  • 1 sell ratings
5/14/2022
  • 0 strong buy ratings
  • 7 buy ratings
  • 4 hold ratings
  • 1 sell ratings
7/13/2022
  • 0 strong buy ratings
  • 8 buy ratings
  • 4 hold ratings
  • 1 sell ratings
8/12/2022

Latest Recommendations

  • 0 strong buy ratings
  • 8 buy ratings
  • 4 hold ratings
  • 1 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
8/9/2022CitigroupBoost Price Target$27.00Low
8/8/2022CICC ResearchInitiated CoverageOutperform$27.30Low
8/4/2022MizuhoLower Price TargetNeutral$34.00 ➝ $30.00Low
7/6/2022Deutsche Bank AktiengesellschaftLower Price TargetHold$29.00 ➝ $24.00N/A
5/17/2022Deutsche Bank AktiengesellschaftInitiated CoverageHold$29.00N/A
5/5/2022MizuhoBoost Price Target$26.00 ➝ $34.00Medium
5/4/2022CowenUpgradeMarket Perform ➝ OutperformHigh
5/4/2022CowenUpgradeMarket Perform ➝ Outperform$25.00 ➝ $33.00High
3/1/2022The Goldman Sachs GroupLower Price TargetSell$23.00 ➝ $20.00Medium
2/23/2022MizuhoLower Price TargetNeutral$31.00 ➝ $26.00Medium
2/1/2022Bank of AmericaUpgradeUnderperform ➝ NeutralMedium
1/11/2022Piper SandlerLower Price Target$34.00 ➝ $31.00High
1/4/2022Vertical ResearchUpgradeHold ➝ Buy$30.00High
12/15/2021The Goldman Sachs GroupDowngradeNeutral ➝ Sell$22.00 ➝ $23.00High
11/19/2021Evercore ISIReiterated RatingBuy$40.00High
11/9/2021MizuhoBoost Price TargetNeutral$26.00 ➝ $31.00Medium
11/9/2021CitigroupDowngradeBuy ➝ Neutral$31.00Medium
11/5/2021Raymond JamesBoost Price TargetOutperform$26.00 ➝ $33.00Medium
10/12/2021MizuhoInitiated CoverageNeutral$26.00High
10/12/2021CitigroupUpgradeNeutral ➝ Buy$25.00 ➝ $28.00High
10/5/2021Raymond JamesBoost Price TargetOutperform$24.00 ➝ $26.00Medium
10/4/2021Loop CapitalBoost Price TargetBuy$27.00 ➝ $28.00High
10/1/2021Piper SandlerInitiated CoverageOverweight$29.00High
8/30/2021CowenBoost Price TargetOutperform$19.00 ➝ $25.00Low
8/23/2021Loop CapitalBoost Price TargetBuy$24.00 ➝ $27.00Low
8/11/2021Bank of AmericaBoost Price TargetUnderperform$18.00 ➝ $19.00High
8/9/2021CitigroupBoost Price TargetNeutral$22.00 ➝ $25.00High
8/9/2021Vertical ResearchUpgradeSell ➝ Hold$22.00High
4/19/2021Evercore ISIUpgradeIn-Line ➝ Outperform$20.00 ➝ $22.00High
3/15/2021Credit Suisse GroupReiterated RatingNeutral$14.00Medium
3/10/2021CowenInitiated CoverageMarket Perform$19.00Medium
3/5/2021B. RileyInitiated CoverageNeutral$19.00High
2/23/2021Credit Suisse GroupBoost Price TargetNeutral$12.00 ➝ $14.00High
2/22/2021ArgusUpgradeHold ➝ Buy$23.00Low
1/8/2021Raymond JamesDowngradeStrong-Buy ➝ Outperform$18.00 ➝ $24.00High
1/6/2021Smith Barney CitigroupDowngradeBuy ➝ NeutralN/A
1/5/2021Evercore ISIBoost Price Target$10.00 ➝ $20.00N/A
12/9/2020Loop CapitalBoost Price TargetBuy$13.00 ➝ $21.00High
12/7/2020Raymond JamesBoost Price TargetStrong-Buy$14.00 ➝ $18.00Medium
11/9/2020Smith Barney CitigroupUpgradeNeutral ➝ Buy$12.50 ➝ $16.50Medium
11/9/2020Vertical ResearchDowngradeHold ➝ SellMedium
11/6/2020BMO Capital MarketsBoost Price TargetMarket Perform$8.50 ➝ $9.00High
10/8/2020Raymond JamesBoost Price TargetStrong-Buy$9.00 ➝ $14.00High
9/22/2020Evercore ISIInitiated Coverage$10.00Low
8/25/2020Raymond JamesInitiated CoverageStrong-Buy$9.00High
8/10/2020CitigroupBoost Price TargetNeutral$7.00 ➝ $7.50High
8/4/2020Credit Suisse GroupReiterated RatingHold$5.00Medium
7/2/2020Loop CapitalLower Price TargetPositive ➝ Buy$10.00 ➝ $8.00Low
5/12/2020BMO Capital MarketsBoost Price TargetMarket Perform$5.50 ➝ $6.50High
5/12/2020Credit Suisse GroupLower Price TargetNeutral$6.00 ➝ $5.00High
4/9/2020CitigroupLower Price TargetNeutral$9.00 ➝ $6.00High
4/6/2020BMO Capital MarketsDowngradeMarket Perform ➝ UnderperformMedium
4/5/2020BMO Capital MarketsUpgradeUnderperform ➝ Market Perform$7.50 ➝ $5.50High
3/30/2020The Goldman Sachs GroupDowngradeBuy ➝ Neutral$9.50 ➝ $5.00Medium
3/26/2020Vertical ResearchUpgradeSell ➝ HoldLow
3/25/2020KeyCorpInitiated CoverageSector Weight ➝ Sector WeightHigh
2/21/2020Vertical ResearchDowngradeHold ➝ SellHigh
2/21/2020BMO Capital MarketsDowngradeMarket Perform ➝ Underperform$7.50High
2/18/2020Credit Suisse GroupDowngradeOutperform ➝ Neutral$9.00 ➝ $11.00Medium
10/9/2019CitigroupLower Price TargetNeutral$8.25 ➝ $7.50Medium
8/12/2019CitigroupSet Price TargetHold$8.00Medium
8/12/2019Bank of AmericaDowngradeNeutral ➝ Underperform$10.00 ➝ $7.00High
8/7/2019Nomura SecuritiesSet Price TargetHold$9.00Low
7/15/2019CitigroupSet Price TargetHold$8.00Low
5/16/2019ArgusDowngradeBuy ➝ Hold$7.58Medium
5/10/2019Bank of AmericaDowngradeBuy ➝ Neutral$16.00 ➝ $10.00High
5/9/2019GabelliDowngradeBuy ➝ SellHigh
5/9/2019Loop CapitalLower Price TargetBuy$12.00Medium
5/9/2019Credit Suisse GroupReiterated RatingOutperform$18.00 ➝ $12.00Medium
5/9/2019Vertical ResearchDowngradeBuy ➝ HoldMedium
4/15/2019CitigroupDowngradeBuy ➝ Neutral$15.00 ➝ $13.00Medium
3/1/2019Loop CapitalSet Price TargetBuy$18.00High
2/27/2019GabelliInitiated CoverageBuy ➝ Buy$21.00High
2/14/2019Bank of AmericaSet Price TargetBuy$16.00High
2/14/2019Credit Suisse GroupSet Price TargetBuy$18.00High
2/13/2019Loop CapitalLower Price TargetBuy$18.00High
1/16/2019Clarkson CapitalInitiated CoverageBuy ➝ Buy$20.00Medium
1/15/2019Nomura SecuritiesDowngradeBuy ➝ NeutralHigh
1/4/2019Credit Suisse GroupSet Price TargetBuy$20.00High
12/20/2018Credit Suisse GroupReiterated RatingBuy$20.00Medium
12/17/2018Loop CapitalSet Price TargetBuy$22.00Medium
12/13/2018ArgusInitiated CoverageBuy ➝ Buy$21.00Medium
12/3/2018HSBCInitiated CoverageBuy ➝ Buy$22.00High
11/14/2018Buckingham ResearchInitiated CoverageNeutral ➝ Neutral$18.00Medium
11/9/2018Loop CapitalInitiated CoverageBuy ➝ Buy$22.00Medium
11/5/2018Credit Suisse GroupInitiated CoverageOutperform ➝ Outperform$20.00Medium
11/5/2018Nomura SecuritiesInitiated CoverageBuy ➝ Buy$20.00Medium
11/5/2018CitigroupInitiated CoverageBuy ➝ Buy$20.00Low
11/5/2018Bank of AmericaInitiated CoverageBuy ➝ Buy$20.00Low
11/5/2018The Goldman Sachs GroupInitiated CoverageBuy ➝ Buy$22.00Low
10/29/2018BMO Capital MarketsInitiated CoverageMarket Perform$18.00Medium
10/22/2018Vertical ResearchInitiated CoverageBuy ➝ Buy$20.00Low
(Data available from 8/12/2017 forward)

News Sentiment Rating

0.41 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 3 very positive mentions
  • 15 positive mentions
  • 3 negative mentions
  • 0 very negative mentions
1/14/2022
  • 4 very positive mentions
  • 20 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
2/13/2022
  • 5 very positive mentions
  • 17 positive mentions
  • 2 negative mentions
  • 1 very negative mentions
3/15/2022
  • 5 very positive mentions
  • 17 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
4/14/2022
  • 8 very positive mentions
  • 30 positive mentions
  • 3 negative mentions
  • 0 very negative mentions
5/14/2022
  • 5 very positive mentions
  • 12 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
6/13/2022
  • 3 very positive mentions
  • 12 positive mentions
  • 4 negative mentions
  • 1 very negative mentions
7/13/2022
  • 9 very positive mentions
  • 33 positive mentions
  • 4 negative mentions
  • 0 very negative mentions
8/12/2022

Current Sentiment

  • 9 very positive mentions
  • 33 positive mentions
  • 4 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.
Livent logo
Livent Corporation manufactures and sells performance lithium compounds primarily used in lithium-based batteries, specialty polymers, and chemical synthesis applications in North America, Latin America, Europe, the Middle East, Africa, and the Asia Pacific. The company offers lithium compounds for use in applications that have specific performance requirements, including battery-grade lithium hydroxide for use in high performance lithium-ion batteries; and butyllithium, which is used in the production of polymers and pharmaceutical products, as well as a range of specialty lithium compounds, including high purity lithium metal, which is used in non-rechargeable batteries and the production of lightweight materials for aerospace applications. It also provides lithium phosphate, pharmaceutical-grade lithium carbonate, high purity lithium chloride, and specialty organics; and lithium carbonate and lithium chloride for use as feedstock in the process of producing performance lithium compounds. The company was incorporated in 2018 and is headquartered in Philadelphia, Pennsylvania.
Read More

Today's Range

Now: $30.03
Low: $28.51
High: $30.41

50 Day Range

MA: $24.09
Low: $20.10
High: $30.23

52 Week Range

Now: $30.03
Low: $19.35
High: $34.61

Volume

4,495,555 shs

Average Volume

3,243,137 shs

Market Capitalization

$5.38 billion

P/E Ratio

54.60

Dividend Yield

N/A

Beta

2.02

Frequently Asked Questions

What sell-side analysts currently cover shares of Livent?

The following equities research analysts have issued reports on Livent in the last year: Bank of America Co., CICC Research, Citigroup Inc., Cowen Inc, Cowen Inc., Deutsche Bank Aktiengesellschaft, Evercore ISI, Loop Capital, Mizuho, Piper Sandler, Raymond James, The Goldman Sachs Group, Inc., TheStreet, and Vertical Research.
View the latest analyst ratings for LTHM.

What is the current price target for Livent?

12 Wall Street analysts have set twelve-month price targets for Livent in the last year. Their average twelve-month price target is $29.03, suggesting a possible downside of 3.3%. Evercore ISI has the highest price target set, predicting LTHM will reach $40.00 in the next twelve months. The Goldman Sachs Group, Inc. has the lowest price target set, forecasting a price of $20.00 for Livent in the next year.
View the latest price targets for LTHM.

What is the current consensus analyst rating for Livent?

Livent currently has 1 sell rating, 4 hold ratings and 8 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe LTHM will outperform the market and that investors should add to their positions of Livent.
View the latest ratings for LTHM.

What other companies compete with Livent?

Other companies that are similar to Livent include Chemours, Univar Solutions, Ashland Global, Huntsman and Balchem. Learn More about companies similar to Livent.

How do I contact Livent's investor relations team?

Livent's physical mailing address is 2929 WALNUT STREET, PHILADELPHIA PA, 19104. The company's listed phone number is (215) 299-5900 and its investor relations email address is [email protected] The official website for Livent is www.livent.com. Learn More about contacing Livent investor relations.